NASS Coverage Recommendations

support the use of PEMF stimulation
as an adjunct to spinal fusion surgery
in high-risk patients.

The STIM onTrack mobile app and Orthofix proprietary Physician Portal enables physicians to remotely view patient adherence to prescribed treatments.

How PEMF Works Video

Orthofix Bone Growth Therapy devices provide a safe and effective non-surgical PEMF treatment to improve fracture healing and fusion success rates by impacting bone healing at the molecular, cellular and tissue level.4-9

Medical Consultants and Advisors

Our Medical Consultants and Advisors provide knowledge and experience in the bone growth therapy market. The members are highly recognized surgeons in addition to doctors of philosophy.

Richard Guyer, M.D. is the Co-founder of the Texas Back Institute and Director of their Spine Fellowship Program. Dr. Guyer is also co-director for the Center for Disc Replacement at Texas Back Institute. He is on the Board of Directors for the Texas Back Institute Research Foundation and served as the President of the North American Spine Society. Additionally, Dr. Guyer is on the editorial board for numerous medical journals including, Spine, The Spine Journal, University of Pennsylvania Orthopedic Journal, and The Journal of American Academy of Orthopedic Surgery.

Dr. Jack Zigler attended Cornell University, receiving a BS with Distinction in 1973. He received an MD cum laude from the Upstate Medical Center (Syracuse, New York) in 1977.

Dr. Zigler completed a residency in Orthopaedic Surgery at Mount Sinai Hospital in New York City in 1981, and then a Fellowship in Spine Surgery and Spinal Cord Injury at Case Western Reserve University in Cleveland, Ohio, with Dr. Henry Bohlman.

After his Fellowship, Dr. Zigler moved to California where he was Chief of the Spinal Injury Service at Rancho Los Amigos National Rehabilitation Hospital from 1982 to 1996. He was also a Clinical Professor of Orthopaedic Surgery at the University of Southern California, and was partner in a private practice in Anaheim, California.

In 1996, Dr. Zigler moved to Dallas, Texas, and has been Fellowship Co-Director at the Texas Back Institute in Plano, Texas, and a former Clinical Associate Professor of Orthopaedic Surgery at the UT-Southwestern School of Medicine, where he currently serves as Medical Director. His practice concentrates on adult spinal disorders and arthroplasty.

Dr. Zigler has authored over 60 articles in peer-reviewed journals and 23 textbook chapters, has edited three textbooks (Spine Trauma; Spinal Arthroplasty), lectures internationally on spine-related topics, and has trained over 100 spine surgeons in his 34 years of clinical and academic practice. He has been married for 40 years and has two children.

Dr. Kris Radcliff is a fellowship-trained spinal surgeon who holds the title of Associate Professor with joint faculty appointments in orthopedic surgery and neurological surgery at Thomas Jefferson University. Dr. Radcliff specializes in the latest techniques in spinal reconstruction including minimally invasive spinal reconstruction procedures and artificial disk replacement.

Dr. Radcliff is actively interested in exploring alternatives to traditional fusion surgery. He recently won the prestigious best paper award at an international meeting of cervical spine experts (Cervical Spine Research Society) for a study comparing cervical disk replacement and fusion.

Dr Radcliff completed his undergraduate education at Harvard University and medical school at Duke University School of Medicine. He completed his orthopedic surgery residency at the prestigious Baylor College of Medicine in Houston, Texas. Following residency, Dr. Radcliff performed fellowship training in Spine Surgery and Spinal Cord Injury at Thomas Jefferson University, widely considered to be one of the top orthopedic and neurosurgical spine fellowships in the world. He has also visited and operated with leading spine surgeons in the nation and around the world.

Dr. Radcliff is an international expert on diagnosis, nonsurgical, and surgical treatment of spinal conditions. He has authored or co-authored seventy six peer-reviewed publications, twenty two textbook chapters on diagnosis and treatment of spinal conditions, and has won numerous research awards. Dr. Radcliff was recently chosen as the liaison of the American Academy of Orthopedic Surgeons to the North American Spine Society Low Back Pain Guideline Committee.

Dr. Radcliff regularly teaches other surgeons at national and international meetings about safely and efficiently performing spine surgery, techniques and complication avoidance in minimally invasive spine surgery, orthopedic basic science, and spine trauma and spinal cord injury.

He is the incoming Chairman of the North American Spine Society Young Surgeons Forum and President of the Association for Collaborative Spine Research. A regular invited faculty member at numerous national and international spine meetings including the prestigious “Contemporary Techniques in Minimally Invasive Cervical and Lumbar Spine Surgery” course in St. Louis, Dr. Radcliff is also on the faculty of the Cervical Spine Research Society meeting, Association for Neurological Surgeons/Congress of Neurological Surgeons Joint Meeting on Spine, North American Spine Society, and American Academy of Orthopedic Surgeons. Dr. Radcliff is also an active member of the Society for Minimally Invasive Spinal Surgery and Lumber Spine Research Society.

Jim Ryaby, PhD joined Orthofix as Chief Scientific Officer in July 2013 after serving as a consultant to Orthofix. Before joining the Company, he served as Vice President of Research and Clinical Affairs for musculoskeletal applications at Mesoblast. Dr. Ryaby has also held the position of Senior Vice President of Research and Clinical Affairs and Chief Scientific Officer at OrthoLogic Corp in Tempe, AZ where he led the development of the CMF technology for spine fusion and nonunions and the TP508 peptide therapeutic development program in orthopedic and diabetic ulcer applications. Additionally, he has served as Adjunct Professor of Bioengineering at Arizona State University. Dr. Ryaby received his PhD degree in cellular and molecular biology from the Mt. Sinai School of Medicine, New York.

Jane Jacob, PhD joined Orthofix as the Senior Director of Clinical Affairs in July 2014. Before joining Orthofix, she was the Director of Clinical Affairs at LDR Spine (Austin, TX) and Manager of Clinical Affairs at DJO Surgical (Austin, TX) for several years. Dr. Jacob obtained her PhD in Neurophysiology and Anatomy & Cell Biology from Case Western Reserve University (Cleveland, OH) and she did her post-doctoral training in cell and molecular neuroregeneration in the Dept. of Neurosurgery. She then spent time as an Assistant Professor of Anatomy and Cell Biology at the University of Oklahoma Health Sciences Center before joining DJO’ s clinical research team. Dr. Jacob’s clinical research career has focused on orthopedics and rheumatology.

Erik Waldorff, PhD, joined Orthofix as a Research Science Specialist in June 2012. Before joining the Company, he served as a Clinical Research Scientist for the Neuromodulation Division at St. Jude Medical where he performed pre-clinical studies in addition to post-market clinical trials for spinal cord stimulation and deep brain stimulation patients. Prior to that Dr. Waldorff held a position as a Postdoctoral Fellow at the Michigan Institute for Clinical and Health Research (MICHR) at the University of Michigan where he led orthopaedic human and animal studies. Dr. Waldorff received his PhD degree in Biomedical Engineering from the University of Michigan (Ann Arbor, Michigan).

News & Events

Visit us at the event below.